Hyaluronic Acid and Vaginal Distress

NCT ID: NCT00890487

Last Updated: 2009-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2009-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this trial is to study the effects of the oral supplementation hyaluronic acid in menopause women with vaginal distress for treatment vaginal distress.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaginal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hyaluroni acid pill

Group Type OTHER

hyaluronic acid pill

Intervention Type OTHER

pill, 220 mg, once a day, three months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

hyaluronic acid pill

pill, 220 mg, once a day, three months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* menopause
* vaginal distress
* no other therapy

Exclusion Criteria

* vaginal infection
* Sjogren Syndrome
Minimum Eligible Age

45 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Messina

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Menopause centre of

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tindara TL La Galia, PhD student

Role: PRINCIPAL_INVESTIGATOR

Centre Menopause

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Menopause centre of the G. Martino University Policlinic

Messina, Sicily, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tindara LT La Galia, PhD student

Role: CONTACT

Phone: +393470635155

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tindara TL La Galia, PhD student

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

30031978

Identifier Type: -

Identifier Source: org_study_id